Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Isaac Shin Chua, M.D.

Title
Institution
Department
Address

Biography
Rice University, Houston, TXBA05/2005Music
McGovern Medical School at UT Health, Houston, TXMD05/2010
Dartmouth Hitchcock Medical Center, Lebanon, NH06/2013Residency in Internal Medicine
Massachusetts General Hospital, Boston, MA06/2017Fellowship in Hospice and Palliative Medicine
Harvard T.H. Chan School of Public Health, Boston, MAMPH05/2019Clinical Effectiveness
CRICO / Harvard Medical School, Boston, MA06/2019Fellowship in Patient Safety and Quality
2013
Excellence in Teaching Award - Department of Medicine
2022
American Academy of Hospice and Palliative Medicine Research Scholar

Overview
Dr. Isaac Chua is an Instructor of Medicine at Harvard Medical School and a palliative care physician at Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, MA. His research focuses on improving care for seriously ill patients with concurrent substance use disorder, evaluating and implementing digital health applications (i.e., telehealth and artificial intelligence) to improve palliative care delivery, and developing novel quality measures in palliative care. He recently received a mentored patient-oriented research career development award (K23) from the National Institute on Aging to develop a patient-reported experience measure that measures goal-concordant care among seriously ill older adults with multimorbidity.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. 1K23AG075250-01 (Isaac Chua) Jun 1, 2022 - May 31, 2027
    NIH/NIA
    A Novel Method for Measuring Goal-Concordant Care in Seriously Ill Older Adults with Multiple Chronic Conditions
    Role: Principal Investigator
  2. (Athena Petrides) Dec 1, 2019 - Nov 30, 2020
    Brigham and Women's Hospital / McGraw Family Opioid Innovator Grant
    DigiToxRx: Treating Pain is No Longer Painful
    Role: Co-Investigator
  3. (Isaac Chua) Oct 10, 2017 - Mar 31, 2019
    Dana-Farber Cancer Institute / Friends of Dana-Farber
    Palliative Telemedicine for Women's Cancer Patients at Dana-Farber
    Role: Principal Investigator

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Bacon M, Kematick B, Suliman I, Scullion B, Chua I, Given S, Lally K. Development of PharmPAL: A Collaborative Practice Pharmacy Clinic in Ambulatory Palliative Care. Am J Hosp Palliat Care. 2022 Sep 02; 10499091221120593. PMID: 36052826.
    Citations:    Fields:    
  2. Chua IS, Olmsted M, Plotke R, Turk Y, Trotter C, Rinaldi S, Kamdar M, Jackson VA, Gallagher-Medeiros ER, El-Jawahri A, Temel JS, Greer JA. Video and In-Person Palliative Care Delivery Challenges before and during the COVID-19 Pandemic. J Pain Symptom Manage. 2022 Dec; 64(6):577-587. PMID: 35985551; PMCID: PMC9383956.
    Citations:    Fields:    Translation:HumansPHPublic Health
  3. Chua IS, Shi SM, Jia Z, Leiter R, Rodriguez JA, Sivashanker K, Yeh IM, Bernacki R, Levine DM. Differences in End-of-Life Care between COVID-19 Inpatient Decedents with English Proficiency and Limited English Proficiency. J Palliat Med. 2022 Nov; 25(11):1629-1638. PMID: 35575745.
    Citations:    Fields:    
  4. Chua IS, Ritchie CS, Bates DW. Enhancing serious illness communication using artificial intelligence. NPJ Digit Med. 2022 Jan 27; 5(1):14. PMID: 35087172; PMCID: PMC8795189.
    Citations:    
  5. Chua IS, Gaziel-Yablowitz M, Korach ZT, Kehl KL, Levitan NA, Arriaga YE, Jackson GP, Bates DW, Hassett M. Artificial intelligence in oncology: Path to implementation. Cancer Med. 2021 06; 10(12):4138-4149. PMID: 33960708.
    Citations: 4     Fields:    Translation:Humans
  6. Chua IS, Fratt E, Ho JJ, Roldan CS, Gundersen DA, Childers J. Primary Addiction Medicine Skills for Hospice and Palliative Medicine Physicians: A Modified Delphi Study. J Pain Symptom Manage. 2021 10; 62(4):720-729. PMID: 33677071.
    Citations:    Fields:    Translation:Humans
  7. Chua IS, Ransohoff JR, Ehrlich O, Katznelson E, Virk ZM, Demetriou CA, Petrides AK, Orav EJ, Schiff GD, Melanson SEF. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study. Pain Physician. 2021 03; 24(2):E191-E201. PMID: 33740356.
    Citations:    Fields:    Translation:HumansPHPublic Health
  8. Chua IS, Shi SM, Levine DM. Place of Death and End-of-Life Care Utilization among COVID-19 Decedents in a Massachusetts Health Care System. J Palliat Med. 2021 03; 24(3):322-323. PMID: 33210957; PMCID: PMC8020559.
    Citations: 3     Fields:    Translation:HumansCells
  9. Lally K, Chua IS, Lin NU, Siegel J, Bernacki R. Using Quality Improvement to Increase Access to Palliative Care. JCO Oncol Pract. 2021 02; 17(2):107-110. PMID: 33197223; PMCID: PMC8258117.
    Citations:    Fields:    Translation:Humans
  10. Chua IS, Jackson V, Kamdar M. Webside Manner during the COVID-19 Pandemic: Maintaining Human Connection during Virtual Visits. J Palliat Med. 2020 11; 23(11):1507-1509. PMID: 32525744.
    Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
  11. Chua I, Petrides AK, Schiff GD, Ransohoff JR, Kantartjis M, Streid J, Demetriou CA, Melanson SEF. Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results. J Gen Intern Med. 2020 01; 35(1):283-290. PMID: 31713040.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  12. Chua IS, Zachariah F, Dale W, Feliciano J, Hanson L, Blackhall L, Quest T, Curseen K, Grey C, Rhodes R, Shoemaker L, Silveira M, Fischer S, O'Mahony S, Leventakos K, Trotter C, Sereno I, Kamdar M, Temel J, Greer JA. Early Integrated Telehealth versus In-Person Palliative Care for Patients with Advanced Lung Cancer: A Study Protocol. J Palliat Med. 2019 09; 22(S1):7-19. PMID: 31486721.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  13. Chua IS, Leiter RE, Brizzi KT, Coey CA, Mazzola E, Tulsky JA, Lindvall C. US National Trends in Opioid-Related Hospitalizations Among Patients With Cancer. JAMA Oncol. 2019 May 01; 5(5):734-735. PMID: 30920595; PMCID: PMC6512252.
    Citations: 11     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Chua's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (60)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.